Through every shift, every emergency, and every patient, our team is with you. Always prepared. Always precise. Always protecting.
Always Delivering.
Ken Miller
Chief Executive Officer
Ken Miller is a seasoned executive who brings over 35 years of leadership experience in the medical device industry to Spectrum Vascular.
Ken’s established ability to drive commercial and operational excellence across both growth-stage and established healthcare organizations has consistently delivered strong revenue growth.
Before joining Spectrum Vascular, Ken held CEO and senior executive leadership roles at multinational companies like Becton Dickinson & Company, and Novo Nordisk, where he built and led high-performing teams and expanded market presence.
Henry Burmeister
Chief Financial Officer
Earlier in his career, Henry held a range of finance roles, including Operations Controller, FP&A Director, and Business Controller. Before transitioning into finance, he began his career as a Measurement & Quality Engineer/Team Lead at Buckeye Pipe Line Company.
Henry holds a BS in Chemical Engineering from Lafayette College and an MBA from Lehigh University. He also successfully passed the Chartered Financial Analyst exams from the CFA Institute and was a varsity football player during his time at Lafayette College.
Doug Shook
Chief Commercial Officer
Doug Shook brings more than two decades of commercial leadership experience in the medical technology space to his role, with deep expertise in driving go-to-market strategies and scaling customer engagement.
He joined Spectrum from ICU Medical, where he served as the Global Business Unit Leader for Vascular Access. Prior to ICU Medical, Doug Shook held commercial leadership roles at Smiths Medical, Access Scientific and CareFusion, manufacturers of premium vascular access devices for the acute and ambulatory care markets.
Doug holds a BS in Biomedical Engineering from Georgia Tech and an MBA from the University of Michigan, where he graduated Magna Cum Laude.
Sharon Klugewicz
SVP, Quality & Regulatory Affairs
With more than 25 years of experience in the medical device and life sciences industries, Sharon Klugewicz has led global regulatory strategy and market access initiatives, including FDA PMA and 510(k) approvals, EU MDR conformity assessments, and international registrations across multiple jurisdictions. She has directed regulatory inspections and notified body audits, and guided organizations through quality system transformations and complex product lifecycle compliance.
Throughout her career, Sharon has established and strengthened enterprise quality management systems, implemented risk-based governance frameworks, enhanced post-market surveillance and complaint handling programs, and supported product development and technology transfers within highly regulated Class II and III device environments. Her leadership has enabled sustainable global market access and regulatory readiness during periods of growth, acquisition integration, and portfolio expansion. Prior to Spectrum Vascular, Sharon held executive leadership roles at Bioventus, Misonix (acquired by Bioventus), Chembio Diagnostics, and Pall Life Sciences (now part of Cytiva, a Danaher company).
Adam Edelhauser
VP of R&D
Adam Edelhauser brings deep expertise in medical device innovation and product development. He joined Spectrum Vascular from Koru Medical Systems, where he was Director of R&D – New Product Development and Sustaining and spearheaded the design, development, and commercialization of cutting-edge infusion solutions delivering over 2 million infusions worldwide annually.
Prior to Koru, Adam was with Becton Dickinson for more than 8 years, where he took on successive roles of greater responsibility, culminating in his promotion to Associate R&D Director – New Product Development, overseeing the development of 14 products valued at over $300M. Earlier in his career, Adam was a Project Engineer at Stryker Orthopedics. Adam holds a BS in Mechanical Engineering from Rutgers University.
John Varela
SVP, Manufacturing & Operations
John Varela brings broad and deep domestic and global experience across manufacturing, operations, and supply chain leadership. He joined Spectrum Vascular from Globus Medical, where he was SVP, Global Operations with responsibility for all aspects of manufacturing, distribution, customer service, and supply chain across 10 sites and worldwide distribution in over 50 countries.
Prior to Globus, John was the Executive Vice President, Global Operations at RTI Surgical, where he had responsibility for RTI’s global manufacturing and distribution sites. Earlier in his career, he worked at Teleflex Medical (formerly Arrow International, Inc.) as Sr. Director of Global Logistics & Demand Planning. John holds a BS in Mechanical Engineering from Pennsylvania State University and an MS in Environmental Engineering from Drexel University.
Deb Litman-Goch
VP of HR & Interim Chief Compiance Officer
Deb Litman-Goch brings more than 20 years of Human Resources experience, beginning her career in the pharmaceutical industry with GlaxoSmithKline (GSK) and later AstraZeneca. While at GSK, she completed her undergraduate degree at the Wharton School of the University of Pennsylvania and went on to earn her MS at the University of Pennsylvania in Organizational Dynamics.
Following her time in pharma, Deb spent several years at International SOS, a global company providing travel assistance for medical and environmental emergencies. After ISOS, she built and led the HR function for the US subsidiary of Medartis, a Swiss-based medical device company, marking her first entry into the medical device space. Deb joined Spectrum Vascular in early 2024, initially as a consultant during the period when SV was acquiring products from AngioDynamics, and then formally stepped into the role of VP of Human Resources/Interim Chief Compliance Officer in September 2025.
